Abstract

Current knowledge on the pathogenesis of diastolic heart failure predominantly rests on case-control studies involving symptomatic patients with preserved ejection fraction and relying on invasive diagnostic procedures including endomyocardial biopsy. Our objective was to gain insight in serum and urinary biomarkers reflecting collagen turnover and associated with asymptomatic diastolic LV dysfunction. We randomly recruited 782 Flemish (51.3% women; 50.5 years). We assessed diastolic LV function from the early and late diastolic peak velocities of the transmitral blood flow and of the mitral annulus. By sequencing urinary peptides, we identified 70 urinary collagen fragments. In serum, we measured carboxyterminal propeptide of procollagen type 1 (PICP) as marker of collagen I synthesis and tissue inhibitor of matrix metalloproteinase type 1 (TIMP-1), an inhibitor of collagen-degrading enzymes. In multivariable-adjusted analyses with Bonferroni correction, we expressed effect sizes per 1-SD in urinary collagen I (uCI) or collagen III (uCIII) fragments. In relation to uCI fragments, e’ decreased by 0.183 cm/s (95% confidence interval, 0.017 to 0.350; p = 0.025), whereas E/e’ increased by 0.210 (0.067 to 0.353; p = 0.0012). E/e’ decreased with uCIII by 0.168 (0.021 to 0.316; p = 0.018). Based on age-specific echocardiographic criteria, 182 participants (23.3%) had subclinical diastolic LV dysfunction. Partial least squares discriminant analysis contrasting normal vs. diastolic LV dysfunction confirmed the aforementioned associations with the uCI and uCIII fragments. PICP and TIMP-1 increased in relation to uCI (p<0.0001), whereas these serum markers decreased with uCIII (p≤0.0006). Diastolic LV dysfunction was associated with higher levels of TIMP-1 (653 vs. 696 ng/mL; p = 0.013). In a general population, the non-invasively assessed diastolic LV function correlated inversely with uCI and serum markers of collagen I deposition, but positively with uCIII. These observations generalise previous studies in patients to randomly recruited people, in whom diastolic LV function ranged from normal to subclinical impairment, but did not encompass overt diastolic heart failure.

Highlights

  • Diastolic heart failure, known as heart failure with preserved ejection fraction (HFpEF) represents half of all heart failure cases

  • Partial least squares discriminant analysis contrasting normal vs. diastolic left ventricular (LV) dysfunction confirmed the aforementioned associations with the urinary collagen I (uCI) and uCIII fragments

  • Diastolic LV dysfunction was characterised by impaired relaxation in 68 patients (37.4%) or an elevated filling pressure in the presence of a normal (90 [49.5%]) or low (24 [13.2%]) age-specific E/A ratio [6,21]

Read more

Summary

Introduction

Known as heart failure with preserved ejection fraction (HFpEF) represents half of all heart failure cases. It has a prognosis as dire as heart failure with reduced ejection fraction with a rate of cardiovascular mortality of over 30% within one year of the first hospital admission. Information on the asymptomatic phases of the disease remains scarce. This knowledge gap is relevant, because the prevalence of asymptomatic diastolic LV dysfunction in the general population is as high as 25%[6] with a 10% risk of deterioration over 5 years [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call